Investing Profile

Maha Katabi

InvestorVC
General Partner at Sofinnova Investments
sofinnova.com/team/maha-katab...Montreal
Photo of Maha Katabi, General Partner at Sofinnova Investments
Your Intro Paths to Maha Katabi

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Maha Katabi on

cb
Current Investing Position
Sofinnova Investments General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
12

Maha Katabi is on these Sector & Stage Rankings

Maha Katabi's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Aaron Royston (venBio), Charles Homcy (Third Rock Ventures), Chris Garabedian (Perceptive Advisors), Jeffrey Tong (Third Rock Ventures)
Star Therapeutics
Series CSep 2023$90M
$90M
Co-investors: Carl Gordon (OrbiMed), Beth Seidenberg (Westlake Village BioPartners)
Quanta Therapeutics
Series DMay 2023$51M
$110M
Co-investors: Arjun Goyal (Vida Ventures)
RayzeBio
Series DSep 2022$160M
$420M
Co-investors: Jerel Davis (Versant Ventures), Aaron Royston (venBio), Bong Koh (Venrock), bong koh (KohFounders)
Gyroscope Therapeutics
Series CMar 2021$150M
$210M
Co-investors: Robert Tansley (Cambridge Innovation Capital), Wouter Joustra (Forbion), Dmitrij Hristodorov (Forbion)
Vera Therapeutics
Series CJan 2021$80M
Series UnknownJan 2020
$110M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Kurt von Emster (Abingworth), Beth Seidenberg (Westlake Village BioPartners)
Aerovate Therapeutics
Series AAug 2020$73M
$73M
Apellis Pharmaceuticals
Series EAug 2017$60M
$60M